Data Integrity and Worldwide Regulatory Guidance
Abstract
Good storage of data & record management are critical elements of pharmaceutical quality system. Data integrity refers to maintaining & assuring the accuracy & consistency of data over its entire life-cycle in compliance with its applicable regulatory requirements. Data integrity is mandatory for the regulated pharmaceutical industry, as processing and disposition decisions regarding product quality, safety, efficacy, purity, and compliance with the applicable regulatory requirements are made based on data that is recorded and reported. Data integrity risk should be assessed, mitigated, communicated & reviewed throughout the data life cycle. Healthcare industries should be designed Record-keeping methodologies and systems, in a way that encourages compliance and assures data quality and reliability.
References
2. MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015. Medicines and Healthcare Products Regulatory Agency.
3. Siegfried Schmitt, Principal Consultant, PAREXEL® Consulting ‘Data Integrity: FDA and Global Regulatory Guidance’ Jan_2015.
4. https://www.gov.uk/...data/.../Data_integrity_definitions_and_guidance.
5. Jeanne Moldenhauer “Data Integrity Issues in Pharmaceutical Companies: Part 2 | IVT” Jul 16, 2015.

